London · Pre-Seed–Seed · 15 people tracked
Find your way into Zinc
Sign up to see every warm intro you have to Zinc
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Zinc team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Zinc operates as a mission-driven venture builder dedicated to accelerating Science-for-Impact innovation. It works across the entire ecosystem to build the conditions, capabilities, and coalitions needed for transformative change, aiming to build a better future for both people and the planet. Rather than acting solely as a traditional investor, Zinc creates new ventures and supports founders through a network of Visiting Fellows (experts and advisors from business, academia, design, technology, and the public sector), an executive coaching network for personal and team development, and partnerships with investors and organisations that help founders gain traction with users and drive growth.
Source: firm website, verified Aug 3, 2026.
Team · 15 people
from the firm's website & curatedFounder mafia
The Zinc mafia →11 people who came through Zinc went on to found or lead other companies.
What they invest in
from 8 of 20 portfolio companiesAI & Machine Learning ×4Biotech ×4Deep Tech ×4Healthtech ×3Medical Devices ×3Cleantech ×2Climate Tech ×1Developer Tools ×1
HQs:United Kingdom×5United States×1
Investments · 20 tracked
founders shown can be your intro pathBy year:2024 · 22023 · 13 dated
Novai applies advanced molecular and computational approaches to eye disease, supporting clinicians and researchers in translating scientific findings into patient treatment options.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesReading, GB
Prof. Francesca Cordeiro(Founder, Director & Chief Executive Officer)Prof. M. Francesca Cordeiro(Founder & CEO)MARIA FRANCESCA CORDEIRO(Director)
BoardKARL DAVID KEEGAN(Director)STEPHEN ROY PAGE(Director)
Board seatNatalie Pankova· per SEC Form D · $1.1M raise · filed May 2023
Co-investorsAnglia Capital GroupAscensionExSight VenturesThe FSE GroupInBC Investment Corp.
Anocis is a pharmaceutical drug discovery company focused on early-stage development in neuroscience, particularly ion channel research.
AI & Machine LearningBiotechHealthtechMedical Devices
Dermott O'Callaghan(CSO)Andy McElroy(Acting CEO)
Clyde Hydrogen develops modular hydrogen production systems ranging from 100kW to 100MW+ for applications including emergency backup power, industrial energy storage, and mobility refueling.
CleantechDeep TechEnergyGlasgow, GB
Prof Mark Symes(CTO)Dr Matt Lees(CEO)Dr Jos Trehern(CSO)
Co-investorsOne Planet Capital
CO2Volt develops high-performance acidic CO₂ electrolysers that convert captured carbon dioxide into valuable chemicals, fuels, and industrial feedstocks.
CleantechClimate TechDeep TechLiverpool, GB
Alex Cowan(CTO)in
ionSIGHT provides an AI-driven analytical platform using native mass spectrometry to analyze protein structure and interactions for drug discovery applications.
AI & Machine LearningBiotechDeep Tech
Dr Rod Chalk(CEO)Dr Weston Struwe(CSO)Dr Mark van der Wilk(CTO)
Co-investorsOxford University Innovation
Neurolase develops AI-powered technology for brain surgery, aiming to improve surgical precision and patient outcomes in neurosurgery, particularly for brain tumor resection.
AI & Machine LearningDeep TechHealthtechMedical Devices
Monika Kott(Co-Founder & CEO)inBabar Vaqas(Co-Founder & CMO)in
Co-investorsOxford Technology Management
Serenatis Bio develops small-molecule drugs targeting glutamate and dopamine pathways to treat obsessive-compulsive disorder, a mental health condition with limited effective therapeutic options.
BiotechMental HealthCambridge, GB
Nick Sireau(Executive Chairman & Co-founder)inDavid Cavalla(CEO & Co-founder)in
Co-investorsP53 Invest
Speek offers a conference calling service for web and mobile users that replaces dial-in numbers with a personal link for each host.
Developer ToolsDulles, US
Andy Powers(Executive Officer, Director, Promoter)Danny BoiceJohn Bracken
BoardJennifer Hsin(Director)Alexander Pessala(Director)
Co-investors500 GlobalMiddleland Capital
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
AI & Enabling TechnologiesBioharvClinical ServicesComponents & MaterialsEngineering BiologyEngineering Process TechnologiesEnvironmentGreen Technology DevicesKilo GenMedical DevicesMigrationTherapeutics
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Frequently asked questions
- How many investments has Zinc made?
- Zinc has 20 tracked investments.
- What stage does Zinc invest at?
- Zinc invests at the Pre-Seed, Seed stages.
- What sectors does Zinc focus on?
- Zinc focuses on Biotech, Circular Economy, Cleantech, Climate Tech, Deep Tech, Digital Health, Energy, FemTech, Healthtech, Impact & Social Good, Mental Health, New Materials, Robotics.
- Where is Zinc located?
- Zinc is headquartered in London, GB.
Media · Podcasts & interviews
featuring the teamChangemakers: Ella Goldner, co-founder of ZINC VC
Virgin StartUp · Ella Goldner
4: Ella Goldner of Zinc - Creating Solutions to Women's Emotional & Mental Health
Impact Hustlers - Entrepreneurs with Social Impact · Ella Goldner
We’re live with Zinc VC co-founder Paul Kirby, who is explaining the background of Zinc, the social business accelerator! | By LSE Generate
Paul Kirby · facebook.com
Similar investors
Everywhere Ventures is an early-stage venture firm that writes pre-seed checks and is backed by a community of founder and operator LPs.
Future Positive Capital is a venture firm backing entrepreneurs building companies that address large-scale global challenges across health, sustainability and technology.
Giant Ventures is a venture capital firm investing in technology that transforms civilization's foundational systems across sectors including AI, energy, materials, industry, work, finance, biology and healthcare.
Norrsken VC is a European early-stage venture capital firm investing in technology addressing major global challenges across energy, industry and healthcare, born out of the Norrsken ecosystem for impact-focused founders.
Raisewell Ventures is a global early to mid-stage venture fund bridging Silicon Valley and Southeast Asia, investing in deep tech to pursue both financial returns and economic and social impact.













































